Get 20% lifetime commission for referring investors to digrin.com
here.
Innate Pharma S.A. ( IPHYF) - Key Metrics
IPHYF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.03 | -$0.21 | -$0.22 | -$0.22 |
| 2025Q4 | $0.01 | -$0.30 | -$0.24 | -$0.24 |
| 2025Q2 | $0.06 | -$0.25 | -$0.37 | -$0.37 |
| 2024Q4 | $0 | -$0.30 | -$0.12 | -$0.12 |
| 2024Q2 | $0.15 | -$0.31 | $0.04 | $0.03 |
IPHYF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.72 |
| 2025Q4 | 0% | -1.52 |
| 2025Q2 | 0% | -1.65 |
| 2024Q4 | 0% | -2.33 |
| 2024Q2 | 0% | -1.45 |
IPHYF
Price: $1.51
52 week price:
Earnings Per Share: -0.64 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 141.7 million